Date,Title,Source
2025-09-06T06:16:56Z,Biotech Stocks To Consider – September 4th,ETF Daily News
2025-09-05T09:41:12Z,Biotech Stocks To Consider – September 2nd,ETF Daily News
2025-09-05T05:42:51Z,Top Biotech Stocks Worth Watching – September 3rd,ETF Daily News
2025-09-04T08:32:58Z,Promising Biotech Stocks To Add to Your Watchlist – September 1st,ETF Daily News
"Mon, 08 Sep 2025 21:11:15 GMT",ABBV-706 Yields Durable Responses and Is Deemed Tolerable in R/R SCLC - OncLive,OncLive
"Mon, 08 Sep 2025 12:25:20 GMT",Health Canada Approval of ELAHERE Could Be a Game Changer for AbbVie (ABBV) - simplywall.st,simplywall.st
"Mon, 08 Sep 2025 07:43:00 GMT",1 Reason Every Investor Should Know About AbbVie (ABBV) - The Motley Fool,The Motley Fool
"Mon, 08 Sep 2025 19:14:02 GMT",AbbVie’s ABBV-932 Study: A Step Forward in Drug Safety and Efficacy - TipRanks,TipRanks
"Tue, 09 Sep 2025 06:16:29 GMT",AbbVie (ABBV) Stock Dips While Market Gains: Key Facts - sharewise.com,sharewise.com
"Mon, 08 Sep 2025 17:49:09 GMT",AbbVie’s ABBV-932 Study: A Closer Look at Bioavailability and Market Impact - MSN,MSN
"Sat, 06 Sep 2025 17:17:05 GMT",AbbVie (ABBV) Declares US$1.64 Quarterly Dividend for Shareholders - Yahoo Finance,Yahoo Finance
"Mon, 08 Sep 2025 14:42:19 GMT",J&J vs. AbbVie: Which Healthcare Powerhouse Is Better Positioned? - The Globe and Mail,The Globe and Mail
"Mon, 08 Sep 2025 08:35:40 GMT",Is ABBV forming a breakout pattern - July 2025 Closing Moves & Scalable Portfolio Growth Methods - beatles.ru,beatles.ru
"Mon, 08 Sep 2025 08:58:15 GMT",1 Reason Every Investor Should Know About AbbVie (ABBV) - MSN,MSN
"Mon, 08 Sep 2025 10:34:37 GMT",1 Reason Every Investor Should Know About AbbVie (ABBV) - sharewise.com,sharewise.com
"Sun, 07 Sep 2025 17:17:29 GMT",AbbVie’s New Phase 1 Study: A Closer Look at ABBV-8736 - TipRanks,TipRanks
"Sun, 07 Sep 2025 16:54:17 GMT",AbbVie’s ABBV-383 Study: A New Hope for Multiple Myeloma Treatment? - TipRanks,TipRanks
"Sun, 07 Sep 2025 17:09:49 GMT",AbbVie’s ABBV-277 Study: A New Frontier in Drug Safety Evaluation - TipRanks,TipRanks
"Sun, 07 Sep 2025 17:09:16 GMT",AbbVie’s ABBV-525 Study: A Potential Game-Changer in B-Cell Malignancies - TipRanks,TipRanks
"Sun, 07 Sep 2025 16:47:23 GMT",AbbVie’s Promising Phase 1 Study on ABBV-706 in Advanced Solid Tumors - TipRanks,TipRanks
"Sun, 07 Sep 2025 17:47:32 GMT",AbbVie’s Promising Phase 2 Study on ABBV-932 for Anxiety Disorder - TipRanks,TipRanks
"Sun, 07 Sep 2025 17:11:34 GMT",AbbVie’s Promising Study on ABBV-706 for Small Cell Lung Cancer - TipRanks,TipRanks
"Fri, 05 Sep 2025 13:09:32 GMT",AbbVie (ABBV) Declares $1.64 Quarterly Dividend; 3.1% Yield - StreetInsider,StreetInsider
"Sat, 06 Sep 2025 07:41:15 GMT",What is the PEG ratio of ABBV - July 2025 Momentum & Fast Moving Market Watchlists - 강소기업뉴스,강소기업뉴스
"Sat, 06 Sep 2025 09:25:39 GMT",ABBV Shows Risk Reward Favoring Upside - Market Trend Review & Weekly Consistent Profit Watchlists - beatles.ru,beatles.ru
"Thu, 04 Sep 2025 19:40:26 GMT",AbbVie Inc. (NYSE:ABBV) Is a Favorite Amongst Institutional Investors Who Own 74% - 富途牛牛,富途牛牛
"Thu, 04 Sep 2025 17:48:45 GMT",AbbVie’s ABBV-400 Study: A New Hope for Advanced Solid Tumors - TipRanks,TipRanks
"Fri, 05 Sep 2025 18:26:02 GMT",Is ABBV backed by strong institutional buying - July 2025 Big Picture & Safe Capital Allocation Plans - خودرو بانک,خودرو بانک
"Sun, 07 Sep 2025 21:50:34 GMT",Is ABBV backed by strong institutional buying - Weekly Trade Report & Daily Profit Focused Screening - 강소기업뉴스,강소기업뉴스
"Sat, 06 Sep 2025 09:02:38 GMT",What is ABBV’s book value per share - July 2025 Trade Ideas & Step-by-Step Swing Trade Plans - خودرو بانک,خودرو بانک
"Mon, 08 Sep 2025 07:10:42 GMT",What hedge funds are buying ABBV - Weekly Trading Summary & AI Powered Market Entry Strategies - 뉴스영,뉴스영
"Fri, 05 Sep 2025 01:54:51 GMT",What is ABBV’s book value per share - Weekly Trade Summary & Stock Timing and Entry Methods - خودرو بانک,خودرو بانک
"Tue, 09 Sep 2025 06:37:48 GMT",How to integrate ABBV into portfolio analysis tools - Portfolio Gains Report & Reliable Breakout Stock Forecasts - Newser,Newser
"Mon, 08 Sep 2025 19:52:32 GMT",How to integrate ABBV into portfolio analysis tools - Take Profit & Verified Swing Trading Watchlist - Newser,Newser
"Tue, 09 Sep 2025 06:45:00 GMT",Sentiment analysis tools applied to ABBV - Earnings Beat & AI Enhanced Execution Alerts - Newser,Newser
"Tue, 09 Sep 2025 03:02:38 GMT",Is ABBV stock poised for growth - Rate Cut & High Conviction Buy Zone Picks - Newser,Newser
"Tue, 09 Sep 2025 06:48:02 GMT",Why ABBV is moving today - 2025 Earnings Surprises & High Accuracy Investment Entry Signals - Newser,Newser
"Tue, 09 Sep 2025 05:37:18 GMT",Using Bollinger Bands to evaluate ABBV - 2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - Newser,Newser
"Tue, 09 Sep 2025 05:42:50 GMT",What high frequency data says about ABBV - July 2025 Sentiment & Fast Gain Swing Alerts - Newser,Newser
"Tue, 09 Sep 2025 03:18:12 GMT",What institutional flow reveals about ABBV - July 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser,Newser
"Mon, 08 Sep 2025 19:18:22 GMT",Using RSI to spot recovery in ABBV - July 2025 Sector Moves & Weekly Market Pulse Updates - Newser,Newser
"Mon, 08 Sep 2025 20:07:45 GMT",ABBV stock daily chart insights - July 2025 Summary & Real-Time Volume Analysis Alerts - Newser,Newser
"Tue, 09 Sep 2025 02:20:29 GMT",Why ABBV is moving today - July 2025 Summary & Real-Time Market Sentiment Reports - Newser,Newser
2025-09-08T10:43:00,1 Reason Every Investor Should Know About AbbVie (ABBV),Yahoo
2025-09-06T20:17:05,AbbVie (ABBV) Declares US$1.64 Quarterly Dividend for Shareholders,Yahoo
2025-09-05T16:07:00,AbbVie Declares Quarterly Dividend,Yahoo
2025-09-04T16:17:00,Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?,Yahoo
2025-09-04T13:41:02,AbbVie and Genmab’s Epkinly shows outpatient viability in Phase II trial,Yahoo
2025-09-04T12:46:00,Anti-Parkinson's Drugs Global Market Research Report 2025-2030 | $9.2 Bn Opportunities Driven by Increased Awareness in Emerging Countries and a Robust Pipeline of Innovations,Yahoo
2025-09-04T12:05:13,Health Canada approves AbbVie’s Elahere for ovarian cancer,Yahoo
